Leanne Clevenger

h-index

Research activity per year

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Education/Academic qualification

Residency, Cleveland Clinic, Cole Eye Institute

2022

Doctor of Medicine, Baylor University

2018

Bachelor of Science, Wake Forest University

2013

Fingerprint

Dive into the research topics where Leanne Clevenger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Finished
1 Active

A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy (Protocol AP)
Clevenger, L. (PI)
Jaeb Center for Health Research Foundation Incorporated
1/14/26 → 1/14/28
Project: Research project
Study Start Up Costs Only: Quantum: A Phase 3, Randomized, Double-Masked, Active-Controlled Study of the Efficacy and Safety of 8 mg Aflibercept in Participants with Macular Edema Following Retinal Vein Occlusion
Clevenger, L. (PI)
Regeneron Pharmaceuticals
5/16/25 → 8/16/25
Project: Research project

7 Article
2 Comment/debate
1 Review article

Demographics, Presenting Features, and Outcomes of Adult Patients with Ocular Trauma
Clevenger, L. M., Cao, J. L., Steinkerchner, M. S., Nowacki, A. S. & Yuan, A., 2024, In: Journal of Ophthalmology. 2024, 8871776.
Research output: Contribution to journal › Article › peer-review

Open Access
4 Scopus citations
A novel ocular phenotype associated with pathogenic variants in MFSD8 leading to macular dystrophy
Beckman, M., Clevenger, L., DeBenedictis, M. J., Yuan, A. & Sharma, S., 2023, In: Ophthalmic Genetics. 44, 6, p. 606-609 4 p.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Clustering of uveal melanoma: County wide analysis within Ohio
Clevenger, L. M., Wrenn, J. D., Bena, J., Sodhi, G., Tullio, K. & Singh, A. D., Aug 2023, In: PLoS ONE. 18, 8 August, e0290284.
Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations
FIVE WAYS iOCT CAN ENHANCE VITREORETINAL SURGERY: These surgical scenarios can be safer and more efficient with the assistance of intraoperative OCT.
Clevenger, L. M. & Rachitskaya, A. V., 2023, In: Retina Today. 2023, p. 38-40 3 p.
Research output: Contribution to journal › Comment/debate
Identifying geographic atrophy
Clevenger, L. & Rachitskaya, A., May 1 2023, In: Current Opinion in Ophthalmology. 34, 3, p. 195-202 8 p.
Research output: Contribution to journal › Review article › peer-review
6 Scopus citations

Leanne Clevenger, MD

Personal profile

Expertise related to UN Sustainable Development Goals

Education/Academic qualification

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy (Protocol AP)

Study Start Up Costs Only: Quantum: A Phase 3, Randomized, Double-Masked, Active-Controlled Study of the Efficacy and Safety of 8 mg Aflibercept in Participants with Macular Edema Following Retinal Vein Occlusion

Demographics, Presenting Features, and Outcomes of Adult Patients with Ocular Trauma

A novel ocular phenotype associated with pathogenic variants in MFSD8 leading to macular dystrophy

Clustering of uveal melanoma: County wide analysis within Ohio

FIVE WAYS iOCT CAN ENHANCE VITREORETINAL SURGERY: These surgical scenarios can be safer and more efficient with the assistance of intraoperative OCT.

Identifying geographic atrophy

Leanne Clevenger, MD

Personal profile

Expertise related to UN Sustainable Development Goals

Education/Academic qualification

Fingerprint

Collaborations and top research areas from the last five years

Projects & Grants

A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy (Protocol AP)

Study Start Up Costs Only: Quantum: A Phase 3, Randomized, Double-Masked, Active-Controlled Study of the Efficacy and Safety of 8 mg Aflibercept in Participants with Macular Edema Following Retinal Vein Occlusion

Research output

Demographics, Presenting Features, and Outcomes of Adult Patients with Ocular Trauma

A novel ocular phenotype associated with pathogenic variants in MFSD8 leading to macular dystrophy

Clustering of uveal melanoma: County wide analysis within Ohio

FIVE WAYS iOCT CAN ENHANCE VITREORETINAL SURGERY: These surgical scenarios can be safer and more efficient with the assistance of intraoperative OCT.

Identifying geographic atrophy